PRRT2 and neoplasm: For example, PKC–PKD is often co-activated with Ras–Raf–Mek–Erk–p90RSK signalling in melanoma [4–8] and historically PKC has been considered oncogenic, stemming from the tumour-promoting actions of its activator phorbol ester.